Log In
Print
BCIQ
Print
Print this Print this
 

KAR4139

  Manage Alerts
Collapse Summary General Information
Company Karus Therapeutics Ltd.
DescriptionPhosphoinositide 3-kinase (PI3K) p110 delta and beta inhibitors
Molecular Target Phosphoinositide 3-kinase (PI3K)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today